BW
OCEA

Boaz Weinstein’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Boaz Weinstein’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-733,927
Closed -$7.63M – 820
2022
Q4 		$7.63M Hold
733,927
– – 0.1% 327
2022
Q3 		$7.48M Hold
733,927
– – 0.08% 435
2022
Q2 		$7.42M Hold
733,927
– – 0.09% 426
2022
Q1 		$7.4M Buy
733,927
+7,638
+1% +$76.6K 0.11% 336
2021
Q4 		$7.26M Buy
+726,289
New +$7.25M 0.11% 270

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Boaz Weinstein's OCEA Position: Q1 2023 in Review

Boaz Weinstein sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 733,927 shares — an estimated $7.63M sold.

Boaz Weinstein first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $7.63M in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • Boaz Weinstein reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Boaz Weinstein sold 733,927 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $7.63M.
  • Boaz Weinstein first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Boaz Weinstein's Ocean Biomedical, Inc. Common Stock position peaked at $7.63M in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Saba Capital Management's 13F filing for Q1 2023, filed 15 May 2023.